0001209191-19-005421.txt : 20190125
0001209191-19-005421.hdr.sgml : 20190125
20190125181524
ACCESSION NUMBER: 0001209191-19-005421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190123
FILED AS OF DATE: 20190125
DATE AS OF CHANGE: 20190125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TANG KEVIN C
CENTRAL INDEX KEY: 0001178579
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 19543511
MAIL ADDRESS:
STREET 1: 4747 EXECUTIVE DRIVE
STREET 2: SUITE 510
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 4550 TOWNE CENTRE COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-01-23
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001178579
TANG KEVIN C
4747 EXECUTIVE DRIVE, SUITE 510
SAN DIEGO
CA
92121
1
0
1
0
Stock Option (Right to Buy)
5.99
2019-01-23
4
A
0
12000
0.00
A
2029-01-23
Common Stock
12000
12000
D
The stock options vest and become exercisable on January 23, 2020, subject to the Reporting Person's continued service to the Issuer through such date.
/s/ Kevin Tang
2019-01-25